Epocal Announces FDA Clearance Of Lactate Test
Epocal, Inc. has announced that it has received U.S. Food and Drug Administration (FDA) clearance to market its new lactate test on the epoc Blood Analysis System. Lactate measurements from the epoc System are used to evaluate acid-base status and for diagnosis and treatment of lactic acidosis. The addition of lactate to the epoc BGEM Test Card further expands the clinical utility of the Company’s point of care blood gas and electrolyte platform.
Read the full story here
-
FDA delays clearance of POC Skin Cholesterol Test
New ABL90 FLEX POC Analyzer by Radiometer Receives 510(k) Clearance
Roche Receives FDA Clearance For U.S. Launch Of Cobas 8000 Modular Analyzer Series For High-Volume Laboratory Testing
Echo Therapeutics Announces Successful Completion Of Clinical Trial For Prelude(TM) SkinPrep System And 4 percent Lidocaine Cream
Abbott Gets FDA Clearance For Molecular Diagnostic Test For Detection Of Chlamydia And Gonorrhea Infections
